Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucose beads formulations in obese healthy subjects
NCT05737927Phase 1Completed
- Sponsor
- Aphaia Pharma
- Start
- Sep 2020
- Primary completion
- Nov 2020
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of APHD-012 (6 arms), sponsored by Aphaia Pharma. Primary endpoint: Glucagon-Like Polypeptide 1 at 10 hours. Started Sep 2020; status: completed.
02
Drugs
APHD-012
Beyond the preview
Go deeper on NCT05737927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05737927.